PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Dynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D AstraZeneca, Gaithersburg 20878, Maryland, United States.\', \'Biological Therapeutics 1, Antibody Discovery and Protein Engineering (ADPE), R&D AstraZeneca, Gaithersburg 20878, Maryland, United States.\', \'Cell Therapeutics, Antibody Discovery and Protein Engineering (ADPE), R&D AstraZeneca, Gaithersburg 20878, Maryland, United States.\', \'Discovery Anti Infection, Microbial Sciences, R&D AstraZeneca, Gaithersburg 20878, Maryland, United States.\', \'Respiratory and Immunology, R&D AstraZeneca, Gaithersburg 20878, Maryland, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1021/acs.analchem.0c02288
?:hasPublicationType
?:journal
  • Analytical chemistry
is ?:pmid of
?:pmid
?:pmid
  • 32966064
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.362
?:rankingScore_hIndex
  • 295
?:title
  • Development of a Parallel Reaction Monitoring Mass Spectrometry Assay for the Detection of SARS-CoV-2 Spike Glycoprotein and Nucleoprotein.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all